1. Home
  2. LPL vs ICUI Comparison

LPL vs ICUI Comparison

Compare LPL & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPL
  • ICUI
  • Stock Information
  • Founded
  • LPL 1985
  • ICUI 1984
  • Country
  • LPL South Korea
  • ICUI United States
  • Employees
  • LPL N/A
  • ICUI N/A
  • Industry
  • LPL Industrial Machinery/Components
  • ICUI Medical/Dental Instruments
  • Sector
  • LPL Technology
  • ICUI Health Care
  • Exchange
  • LPL Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • LPL 3.4B
  • ICUI 3.4B
  • IPO Year
  • LPL 2004
  • ICUI 1992
  • Fundamental
  • Price
  • LPL $3.39
  • ICUI $122.47
  • Analyst Decision
  • LPL Sell
  • ICUI Strong Buy
  • Analyst Count
  • LPL 2
  • ICUI 5
  • Target Price
  • LPL N/A
  • ICUI $196.75
  • AVG Volume (30 Days)
  • LPL 222.7K
  • ICUI 220.2K
  • Earning Date
  • LPL 07-28-2025
  • ICUI 08-06-2025
  • Dividend Yield
  • LPL N/A
  • ICUI N/A
  • EPS Growth
  • LPL N/A
  • ICUI N/A
  • EPS
  • LPL N/A
  • ICUI N/A
  • Revenue
  • LPL $18,624,457,609.00
  • ICUI $2,420,093,000.00
  • Revenue This Year
  • LPL N/A
  • ICUI N/A
  • Revenue Next Year
  • LPL N/A
  • ICUI N/A
  • P/E Ratio
  • LPL N/A
  • ICUI N/A
  • Revenue Growth
  • LPL 23.70
  • ICUI 7.22
  • 52 Week Low
  • LPL $2.43
  • ICUI $117.92
  • 52 Week High
  • LPL $4.61
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • LPL 52.63
  • ICUI 35.10
  • Support Level
  • LPL $3.36
  • ICUI $129.26
  • Resistance Level
  • LPL $3.47
  • ICUI $139.41
  • Average True Range (ATR)
  • LPL 0.09
  • ICUI 4.16
  • MACD
  • LPL -0.01
  • ICUI -1.07
  • Stochastic Oscillator
  • LPL 37.94
  • ICUI 0.59

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: